Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms reducing parasympathetic activity in chronic hypoxia.

The Journal of physiology·2026
Same author

Co-Creation of a Study Protocol to Assess the Effect of Transcranial Direct Current Stimulation in the Management of Fatigue in Children and Young People With Acquired Brain Injury (Fatiguebrain-tDCS).

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Socio-Demographic and Health Data of Adolescents Identifying as Transgender or Gender Diverse in the Born in Bradford's Age of Wonder Cohort.

Wellcome open research·2026
Same author

From waitlists to clinical action: pathway development and research priorities in childhood developmental regression.

The Lancet. Child & adolescent health·2026
Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same author

Neuroimaging in cerebral folate deficiencies.

Pediatric radiology·2026

Related Experiment Video

Updated: May 30, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Paediatric UK demyelinating disease longitudinal study (PUDDLS).

Michael Absoud1, Carole Cummins, Wui K Chong

  • 1School of Health & Population Sciences, University of Birmingham, Birmingham, UK. michaelabsoud@childdemyelination.org.uk

BMC Pediatrics
|July 30, 2011
PubMed
Summary
This summary is machine-generated.

Childhood Multiple Sclerosis (MS) studies can predict future trends in adult MS epidemiology. Researching early demyelinating events in children offers insights into MS pathogenesis and environmental factors.

More Related Videos

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: May 30, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neurology
  • Epidemiology
  • Pediatrics

Background:

  • Childhood Multiple Sclerosis (MS) accounts for at least 5% of cases, with diagnosis following a second demyelinating event.
  • Changes in adult MS incidence and sex ratios, along with higher risk in children of immigrants, suggest pediatric cohorts may indicate emerging trends.
  • Studying pediatric MS from the first demyelinating event can test hypotheses on changing epidemiology and inform understanding of MS pathogenesis.

Purpose of the Study:

  • To establish the natural history, predictors, and outcomes of childhood central nervous system (CNS) inflammatory demyelinating diseases.
  • To create a prospective, longitudinal cohort of children experiencing their first CNS inflammatory demyelinating event for long-term follow-up.
  • To build a biological sample archive for future research, including biomarker validation, and to facilitate international collaboration.

Main Methods:

  • The Paediatric UK Demyelinating Disease Longitudinal Study (PUDDLS) is a prospective, longitudinal observational study.
  • Recruitment of children with a first CNS inflammatory demyelinating event across UK centers over approximately 5 years.
  • Establishment of a biological sample archive (CSF, serum, DNA) and consent for future contact, alongside international collaboration and data sharing.

Main Results:

  • The study is designed to capture the initial phase of pediatric demyelinating disease.
  • It aims to identify predictors and outcomes for childhood CNS inflammatory demyelinating diseases.
  • The PUDDLS cohort will enable validation of novel biomarkers and investigation of genetic and environmental interactions in MS.

Conclusions:

  • Pediatric MS populations may represent early indicators of epidemiological shifts observed in adult MS.
  • The early disease window in children provides a unique opportunity to study MS pathogenesis.
  • Investigating childhood demyelinating events can yield insights into the changing epidemiology and etiology of Multiple Sclerosis.